With the latest drop of documents from Pfizer, has revealed that Pfizer reported to the U.S. Food and Drug Administration (FDA) it was aware of 1,223 reports of deaths following the vaccine. The deaths, a subset of 42,086 case reports listing 158,893 adverse events, occurred between December 1, 2020, and February 28, 2021. One released document, “Cumulative Analysis of Post-authorization Adverse Event Reports,” states that the “magnitude of underreporting [of adverse events] is unknown.” “Due to the large numbers of spontaneous adverse event reports received for the product, the MAH (Marketing Authorisation Holder) has prioritised the processing of serious cases, in order to meet expedited regulatory reporting timelines and ensure these reports are available for signal detection and evaluation activity.”
The report continued: “Pfizer also taken a [sic] multiple actions to help alleviate the large increase of adverse event reports. This includes significant technology enhancements, [sic] and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.” Thus, the number of adverse events reported overwhelmed Pfizer’s expectations, yet Pfizer concluded, “The findings of these signal detection analyses are consistent with the known safety profile of the vaccine.” However, that optimistic conclusion is not consistent with the evidence of adverse effects. Through February 28, a total of 42,086 recipients (cases) reported 158,893 events, or adverse reactions to the Pfizer vaccine. Approximately 50 percent of these events were deemed serious and 1,223 recipients of the vaccine had a fatal outcome, with over 11,000 not recovering. Once upon a time, a vaccine having these results would have been shut down.